This module gives the possible T-cell epitope derived from Virulence factor of various pathogenic bacteria. The following epitope has been predicted using ProPred, LBtope and VaxinPAD. So these eptipe have high probality to bind with MHC-II as well as will act vaccine adjuvant.

EpitopeScoreIDStart PositionParent Protein
ILKSKDIKI0.73VFG000963336MKIAVAGSGYVGLSLGVLLSLQNEVTIVDILPSKVDKINNGLSPIQDEYIEYYLKSKQLSIKATLDSKAAYKEAELVIIATPTNYNSRINYFDTQHVETVIKEVLSVNSHATLIIKSTIPIGFITEMRQKFQTDRIIFSPEFLRESKALYDNLYPSRIIVSCEENDSPKVKADAEKFALLLKSAAKKNNVPVLIMGASEAEAVKLFANTYLALRVAYFNELDTYAESRKLNSHMIIQGISYDDRIGMHYNNPSFGYGGYCLPKDTKQLLANYNNIPQTLIEAIVSSNNVRKSYIAKQIINVLEERESPVKVVGVYRLIMKSNSDNFRESAIKDVIDILKSKDIKIIIYEPMLNKLESEDQSVLVNDLENFKKQANIIVTNRYDNELQDVKNKVYSRDIFNRD
ILKSLKILL0.64VFG00202463MKIAIVRLSALGDIIQSAVVLQFIKNFKKDIEIHWFVDEKFEGILKNHPLINKLYALPLKDKKILKSLKILLKARKNNYNAVIDLQGLIKSAIVSRILSRNNFGFDKNSLKESFAHNFYNQKLELDYNENVFVRYLSLTSFMLNTDFNVKNLAFKQDIFSVDENLKQLLNNKLKLDKNEKNILIHVGSSVENKIYPKTKLAILCKLLINEFQQTKIWLAWGNVKEYEFAKEVLNLSGIDETHIELAPKFNLEELMAFTKMMNLIIGNDSGPTHLAFALNKASITIFGATPSYRNAFQTHINKIIDAGKKIQNAKHIDKSDFCITRIEEEDIFKLAKGLLNEK
ILKVSGVIR0.94VFG006548181MKKALYLGAVAFSVAFSMASANEPKIDFNPPNYVEETPSKEFIPELNKLGSLFGQGERPLFADRRAMKPNDLITIIVSEKASANYSSSKDYKSASGGNSTPPRLTYNGLDERKKKEAEYLDDKNNYNFTKSSNNTNFKGGGSQKKSEDLEIVLSARIIKVLENGNYFIYGNKEVLVDGEKQILKVSGVIRPYDIERNNTIQSKFLADAKIEYTNLGHLSDSNKKKFAADAMETQMPY
ILLAKIVRF0.8VFG002539124MIDTTVISAAQLDSTVKAALGNYRRAIFIEKLGWPLPLVDGLEIDQFDRPDTIYVVGKTESGDICGCARLLPTTRPYLLGEVFPDLMGDAAPPCSAHVWEISRFSSSILSGGPDALRQAHRNTRILLAKIVRFAQAAGVKRLITVSPLAVERLLNRLKVHIHRAGPPRLIDGKPVFACWIEVDDITLQALDIEPAADSAAGALRHS
ILLWIIRRL0.99VFG005307242MAVMAYPLVSRLYYRVESNQQIADFDKEKATLDEADIDERMKLAQAFNDSLNNVVSGDPWSEEMKKKGRAEYARMLEIHERMGHVEIPVIDVDLPVYAGTAEEVLQQGAGHLEGTSLPIGGNSTHAVITAHTGLPTAKMFTDLTKLKVGDKFYVHNIKEVMAYQVDQVKVIEPTNFDDLLIVPGHDYVTLLTCTPYMINTHRLLVRGHRIPYVAEVEEEFIAANKLSHLYRYLFYVAVGLIVILLWIIRRLRKKKKQPEKALKALKAARKEVKVEDGQQ
ILMFMAMVV0.82VFG00087521MSNKNVNVRKSQEITFCLLAGILMFMAMVVAGRAEAGVALGATRVIYPAGQKQVQLAVTNNDENSTYLIQSWVENADGVKDGRFIVTPPLFAMKGKKENTLRILDATNNQLPQDRESLFWMNVKAIPSMDKSKLTENTLQLAIISRIKLYYRPAKLALPPDQAAEKLRFRRSANSLTLINPTPYYLTVTELNAGTRVLENALVPPMGESAVKLPSDAGSNITYRTINDYGALTPKMTGVME
ILMFPCLML0.87VFG00130513MNKIYNVTSYVIAILMFPCLMLGDKPLLFLAPISYGVGKLFISFSNNPNFKFSKIVYDVLGFLRLVFIPAMIVFFQDSTIDNLPLGQAYFNQAVIYMSVEFIIGSLFILILSKLFKHEVVSRNSFTLSGSSIYYIVFGLVICGIFVAFPEVRKNISFLIIKTDAMGRGTEATSGLNVLFVMLFQLALALLFLIIAYASYKKYKENPKIIYVVLPLAIGILNISLIVGERRSYQLYTMVAVLTVVSILFSKHKRRINIIIISVGIFVLALMTLYKELYVFNYSSYSEALNSTSVSNLKIVDTLQSYFYGPSNIAASIDYLNYYNGSFKQYLFDNTRAVFGFNFFLDKKQLITSQLFNQLIYGSKQLTGHLISSAGYGIIYFGPLFFYLNLIANIFFAFLSEYIIRKSHSLEVIFIGTYIYMRLITSIFSHPTPLITLISMILVVYVIAIIPGIIIKKFTKKVGIE
ILMGVPGSY0.83VFG001321170MRIIKYLTILVISVVILTSCQSSSSQESTKSGEFRIVPTTVALTMTLDKLDLPIVGKPTSYKTLPNRYKDVPEIGQPMEPNVEAVKKLKPTHVLSVSTIKDEMQPFYKQLNMKGYFYDFDSLKGMQKSITQLGDQFNRKAQAKELNDHLNSVKQKIENKAAKQKKHPKVLILMGVPGSYLVATDKSYIGDLVKIAGGENVIKVKDRQYISSNTENLLNINPDIILRLPHGMPEEVKKMFQKEFKQNDIWKHFKAVKNNHVYDLEEVPFGITANVDADKAMTQLYDLFYKDKK
ILMKNMATI0.64VFG000106139MKIRIVSLIVLGFLIGCKHESIITPTVPADGSGGNALNPGLVGGYLPDIGVPDPIISLSMTLDGNLKFDSSLLCNDQDASHFQISQKDNVFCTINGRSIATFTAPFDANKNGRNTDSEVLSLISADEYRDSPVRQENLQILMKNMATIHGDKISLVFRSTLDALTFENYLRHNLDLPKDQFLEAITEKIANDNQVDKQPSTHVPNISPSFTPGTSSNLNSPFVSANAEESLSYIPTDVIPSLGRLLDSQGRVINGVSYFSNNTRGITGVDKTGAILNDGSFEFSWGDIISFSIDTFELGSTRANKTDFYISELGKDNEGKNAEALIHRYASIDDSKLIIPDKVTQIFSLYPNVINEVISLSLPNGDIELDIGDGKTQIVPGEFFKQFDSGLAALIDQSISPISRFKFEDSLPKKKSAIDSESSQIQDIINKLWGATDTVQANGWKKVDRFHIFHDSTNFYGSTGSARAQAAVNIANSAFPVLMARNDNNYWIDFGKPKAWDSNSLAFITEAPSTVVPDKVSEDTSTFNLPFISLGEIGKGKLMVLGNARYNSVLVCPNGFSWGGTVKNGTCSLSSDRDDMANFFSNVIRYLTGSTSNDVIVGTNIPEVYFKSSGQTMGSKANFELDSRFSKQTQQLTSFHDLDVNTIPLIIINAYDYKGKNINSPYDIPLSADVGSPKLSRSDVTDLIDYINNGGSVLMMETIINTNNSEISRLLDSAGIAFGIGNSVVADGNGPSGGHPDRPRSQREHGIWVIERYAAVEDESSGQQTLPYVINSDGSIEWKYIVENRPDDKPKLEVASWVESEAGDKLITHYAFIDESQHWKKDISGKIIYNVAGKPEVDNASLSLAKNKVLDAFKNSSGQRAYSECKNSEFHYEINCLEYRPGNSIPITGGLYVPRYTDIKLGESEANAMVKAANLGTNIHALYQHERYFRTKGKSGARLNSVDLNRIYQNMSVWLWNDLDYRYDDKQSDELGFKVFTQYLNCYTSNNAGGNTTCPE
ILMRERIRK0.94VFG00082855MLTEDIIPEDKLQEIIQSDDIIKLARKKTYEHLLRARRKSKELKTESRKKIARKMILMRERIRKNNKIKLDKEVNQSIKWVKDIQAIELVLMQDIMNKIHLSLTNALHSLDTSSRINWDDLLNEVVRETLSNNNIVGAIKITKNPDIKLDPGEANNIQLINDANTPHNKIIIENEYIRITLDPLEQISILLNSFKDNYLSIIQE